Should create a new thread for this, because there's a lot to unpack...most of which is positive. I just read it all. Bit of glazing over the F#@k Up IMHO, but if it's what Vince says, I'll believe it for now. Short of re-manufacturing the U.S batch and re-doing the Phase 2...we kinda have to believe.
from EUREKA REPORT (subscription or free 15 day trial)
Did Botanix get it wrong?
Alan Kohler speaks with Vince Ippolito, the President and Executive Chairman of Botanix Pharmaceuticals, about the results from their phase 2 trial of a cannabinoid for acne.
Either way, BOT will bounce back. Zero doubt here.I just bought some more myself.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-471
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.015(3.95%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 37.5¢ | 35.0¢ | $1.972M | 5.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 229793 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 227296 | 5 |
View Market Depth
| Last trade - 10.37am 15/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |